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Previews2010). Complicatingmatters are a number
of studies demonstrating that mice that
are deficient in various genes in the innate
and adaptive immune system have
profound perturbations of their bacterial
flora (Hooper and Macpherson, 2010).
This creates a veritable chicken and egg
conundrum: what contributes most in
themaintenance of host intestinal homeo-
stasis, the flora or the immune system?
Addressing this question, Saha and
colleagues found that (among other differ-
ences in the microbiota) Pglyrp2/,
Pglyrp3/, and Pglyrp4/ mice all had
significantly less Lactobacillus in their
stool than WT mice, whereas Pglyrp1/,
Pglyrp2/, and Pglyrp4/ all had fewer
SFB detected. Together, these results
demonstrate that PGRP expression
modulates normal bacterial floracomposi-
tion. Moreover, stool samples collected
from all four PGRP knockout mice had
a greater capacity than WT stools to
induce proinflammatory factors IL-6 and
CXCL-1 from mouse embryonic fibro-
blasts and peritoneal macrophages. Even
more strikingly, germ-free mice reconsti-
tuted with stool from either Pglyrp2/ or
Pglyrp3/ mice lost more weight and
were more susceptible to DSS-induced
colitis than germ-free mice reconstituted
with stool from WT mice, indicating that
the anti-inflammatory effect of PGRPs is,132 Cell Host & Microbe 8, August 19, 2010 ªat least in part, mediated by maintaining
an anti-inflammatory microbiota. A similar
discovery was recently made by Salzman
and colleagues, who reported that antimi-
crobial a-defensins play a critical role in
shaping the composition of the enteric
microbiota, which, in turn, results in
differences in the lamina propria Th17
immune response (Salzman et al., 2010).
These two studies highlight the growing
complexity of the interactions between
the mammalian host and the enteric
microbiome, in that it is now undeniable
that host genetics affects the composition
of the microbiota, yet these host-induced
changes to the flora now appear to
generate greater than anticipated feed-
back to the mucosal immune system.
The study by Saha et al. opens up inter-
esting questions for future investigations.
An important one will be to determine the
mechanism by which individual PGRPs
shape the composition of the intestinal
microflora and why these closely related
proteins display nonredundant functions.
It is likely that PGRPs would affect the
dynamic balance of microbial communi-
ties in the intestine through their capacity
to bind PG, but the direct demonstration
of this hypothesiswill require further inves-
tigation. Another important issue will be to
determine why PGRP deficiency specifi-
cally polarizes the defective immune2010 Elsevier Inc.response toward Th1-skewed immunity,
which may have an impact on our under-
standing of other intestinal pathologies
displaying a similar inflammatory profile,
such as Crohn’s disease. Finally, because
PGRPs may link PG sensing to intestinal
homeostasis, future work should address
if andhow theexpressionof theseproteins
could modulate the function of the intra-
cellular PG sensors Nod1 and Nod2.REFERENCES
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In this issue of Cell Host & Microbe, O’Gorman et al. (2010) identify a key role for early TLR2-mediated IL-6
production and STAT3 activation in generating protective immunity against poxviruses. These findings high-
light the importance of early inflammatory cytokine production in antiviral defense and have implications for
enhancing vaccination efficacy.Cytokines and interferons (IFNs) play an
important role in host defense against
viruses. In the current paradigm(Figure 1A), IFNs and other cytokines
contribute to induction of an antiviral state
and coordinate antiviral immunity. Initialviral infection activates various conserved
and broadly expressed recognition re-
ceptors, including TLRs, RLRs, and DNA
Figure 1. Role of Cytokines and STATs in Antiviral Responses
(A) Viral infection of cells leads to recognition and signaling by endosomal and cytoplasmic receptors such as TLRs and RLRs, with downstream induction of IFN
and cytokine production. Type I IFNs activate their cognate IFNAR receptor in an autocrine, paracrine, and possibly systemic manner. IFNAR signaling leads to
activation of the STAT1-STAT2-IRF9-containing ISGF3 complex that binds to ISRE DNA elements and induces expression of IFN target genes that are important
for an antiviral state and innate and acquired immune responses. The role of other cytokines induced in the earliest stages of viral infection was not well
appreciated.
(B) IFNs were previously shown to play an important role in host defense against vaccinia virus. The current study shows that vaccinia also activates TLR2, which
typically resides in plasma membranes, leading to production of IL-6 and downstream STAT3 activation. TLR2 and early IL-6-STAT3 signaling are important for
generating protective antibody-mediated immunity against vaccinia virus in mice.
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recognition leads to production of type I
IFNs (IFN-a and IFN-b) and various cyto-
kines. Type I IFNs play a key role in the
earliest stages of host defense by
inducing expression of antiviral genes
that confer a cell-autonomous antiviral
state that suppresses viral replication
and makes uninfected cells refractory to
infection. Virus-induced type I and type II
IFNs, along with inflammatory cytokines,
coordinate the innate immune response
to viruses during the first several days of
infection and subsequently play a key
role in orchestrating a specific acquired
immune response, which involves T and
B cell differentiation and induction of
protective cytotoxic lymphocytes and
neutralizing antibodies. Prior to the
current study (O’Gorman et al., 2010),
the role of cytokines other than IFNs
induced during the early phase of antiviral
immunity (typically from 1 hr to several
days after viral infection) was not well
understood.
Measurements of IFN/cytokine produc-
tion and genetic approaches utilizing
deletion of cytokine and IFN genes havetaught us much about the role of these
molecules in antiviral responses. How-
ever, these approaches do not yield
insight into the key questions of which
cells respond to cytokines in vivo, the
time course of cytokine action, the func-
tional importance of cytokine signaling in
particular cells at specific time points,
and whether cellular responses to cyto-
kines are regulated in parallel with the
well-established regulation of cytokine
production. These important questions
are addressed for mouse poxvirus infec-
tion in the current study using a flow cyto-
metric approach developed by Garry
Nolan’s lab to study cytokine-mediated
activation of Jak-STAT signaling at the
single-cell level in vivo (Krutzik et al.,
2005). In this approach, splenic cells are
isolated after viral infection of mice, and
STAT tyrosine phosphorylation, a marker
of activation, is quantitated in various
cell types, including DCs, T cells, B cells,
and granulocytes. This validated method
allows an unprecedented ability to follow
cellular responses to cytokines in vivo.
Understanding the determinants of
host defense to poxviruses has importantCell Host & Microbe 8clinical implications. The human smallpox
virus (variola) does not induce effective
immune responses and represents one
of the most dangerous human pathogens;
similarly, ectromelia (mousepox) does not
induce protective immunity in certain
mouse strains. In contrast, humans and
mice mount effective immune responses
against the vaccinia poxvirus, leading to
protective immunity that is mainly medi-
ated by neutralizing antibodies. The
effective immune response against
vaccinia and the cross-protection it offers
against smallpox have been exploited to
achieve one of the major advances of
modern medicine, the eradication of
smallpox by immunization with vaccinia.
Thus, understanding the mechanistic
basis for differential immune responses
against vaccinia versus smallpox and ec-
tromelia can lead to approaches to
strengthen host defense against poxvi-
ruses and to design improved vaccination
strategies.
TLR2 and IL-6/STAT3
In their study, O’Gorman et al. first exam-
ined STAT tyrosine phosphorylation in, August 19, 2010 ª2010 Elsevier Inc. 133
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Previewssplenic T cells, B cells, DCs, and granulo-
cytes in vivo 1 hr after intravenous (i.v.)
injection of various TLR ligands. Strik-
ingly, i.v. TLR ligand injection induced
very rapid (readily detectable after 1 hr)
tyrosine phosphorylation of predomi-
nantly STAT1 and STAT3 in more than
half of splenic DCs and CD4+ and CD8+
T cells, with lesser activation of STAT4,
STAT5, and STAT6 at this time point and
substantially less STAT activation in B
cells and granulocytes. Overall, STAT1
activation was primarily dependent on
type I IFNs, while STAT3 activation was
primarily dependent on IL-6. These
results establish that cytokine responses
occur very rapidly in vivo, but only in
certain cell populations; it is not clear
why B cells and granulocytes that express
receptors for IFNs and IL-6 did not mani-
fest a detectable cytokine response.
Another important point to note is that
the early burst of splenic cytokine produc-
tion in response to i.v. TLR ligand injection
is substantial enough to activate STAT
signaling in the majority of DCs and
T cells. Thus, splenic T cells are broadly
exposed to a pulse of Jak-STAT signaling
independent of their antigen specificity;
this signaling pulse may play a role in
conditioning T cells for subsequent
antigen-specific responses (discussed
below).
Similar to TLR ligands, intravenous
injection of the immunizing vaccinia virus
induced STAT3 tyrosine phosphorylation
(pSTAT3) in splenic DCs and T cells, with
an early peak 1 hr after injection and
a lower-amplitude second phase of acti-
vation observed at 7 hr. In contrast to
TLR ligands, vaccinia induced unexpect-
edly low pSTAT1, and this was more
dependent on IFN-g than type I IFNs.
The early induction of pSTAT3wasdepen-
dent on IL-6, consistent with the results
obtained using TLR ligands. Surprisingly,
induction of IL-6 and activation of STAT3
by vaccinia were dependent on TLR2,
which has been previously implicated
mainly in recognition of bacterial lipopep-
tides. An important role for TLR2 and
IL-6 in the control of vaccinia infectionwas
corroborated by experiments showing
increased viral burden and decreased
clearance associated with decreased
serum neutralizing antibodies in TLR2- or
IL-6-deficient mice. Further support for
the importance of IL-6 and STAT3 activa-
tion in the control of poxvirus infection134 Cell Host & Microbe 8, August 19, 2010 ªwas provided by experiments showing
that lethal infection by the pathogenic ec-
tromelia in BALB/c mice was associated
with minimal STAT3 activation.
Collectively, the above-described
experiments establish two unexpected
and important points for host defense
against poxviruses that extend our under-
standing of antiviral immunity (Figure 1B).
First is the importance of rapid IL-6 and
thus inflammatory cytokine production
for successful host defense against
poxviruses. Second is the key role of
TLR2 in antiviral immunity. An emerging
and unexpected role for TLR2 in detection
of viruses (previously thought to be
accomplished by nucleic acid-specific
receptors) is supported by a recent report
showing that monocytic TLR2 mediates
type I IFN production in response to viral
stimulation (Barbalat et al., 2009). Viral
ligands that are recognized by TLR2 are
not known, and recognition may occur
via TLR2-associated coreceptors such
as integrins or scavenger receptors.
Another important issue is whether and
how an early burst of STAT3 signaling
that peaks 1 hr postinfection can con-
tribute to effective antiviral immunity.
Direct testing of the importance of early
signaling by selectively ablating only the
first hour of IL-6-STAT3 signaling cannot
be achieved using currently available
experimental approaches. Instead, the
authors used a gain-of-function ap-
proach and, remarkably, showed that
just one injection of IL-6 at the time of
vaccinia infection can rescue antiviral
immunity in TLR2-deficient mice. Even
more impressive is that one injection of
the TLR2 ligand PAM3CSK4 at the time
of ectromelia infection was more effec-
tive at reducing viral burden than thera-
peutic vaccination. Surprisingly, the early
burst of TLR2-mediated IL-6-STAT3
signaling did not affect the innate
response to vaccinia, but instead was
important for subsequent generation of
neutralizing antibodies. It is possible
that an early wave of IL-6 signaling can
condition later stages of T cell differenti-
ation and helper function, possibly
through the induction of IL-21 or other
cytokines (Dienz et al., 2009). Overall,
these results potentially have profound
significance for designing approaches
to enhance the efficacy of antiviral
vaccines by coadministration of cyto-
kines or TLR ligands.2010 Elsevier Inc.Where’s the IFN Response?
An important point to consider is related
to ‘‘the dog that did not bark’’—the
authors did not detect a type I IFN
response (as assessed by STAT1 activa-
tion) in the cells examined, despite con-
firming the importance of type I IFNs for
host defense against poxviruses. One
potential explanation is that type I IFN
signaling was below the threshold of
detection of the flow cytometric assay
that was used or occurred only at later
time points. This issue could be ad-
dressed by extending the analysis to
include additional cell types, later time
points, analysis of pSTAT2 (preferentially
induced by type I IFNs), and perhaps
most importantly by measuring expres-
sion of IFN-inducible genes. Type I IFNs
can robustly induce gene expression at
low or even undetectable levels of
signaling, and analysis of IFN target
gene expression (‘‘IFN signature’’) in vivo
can provide an important approach
complementary to in vivo signaling
studies, as can in vivo imaging ap-
proaches. A more interesting explanation
for low pSTAT1 in these experiments is
that IFN signaling is regulated in vivo,
either by virus-encoded products (as
partially investigated in the current study)
or by host cell-expressed viral recognition
receptors or other immunoreceptors that
cross-regulate IFN receptor signaling
(Ivashkiv, 2008; Wang et al., 2010). Such
regulation of IFN signaling during viral or
bacterial infection in vivo has been previ-
ously described (Hotson et al., 2009;
Nguyen et al., 2002). Suppression of IFN
signaling by viral products would repre-
sent a pathogenic mechanism to evade
antiviral responses; modulation of IFN
signaling by host cell receptors would
represent a fine-tuning of IFN responses
(Figure 1A) to maintain host defense while
avoiding toxicity associated with high IFN
expression. Thus, the lack of detection of
an IFN response represents both a limita-
tion and strength of the experimental
approach used. The limitation is that
important host defense mechanisms
may not be detected; the strength, that
this method allows investigation of the
regulation of cytokine signaling in vivo.
Conclusions
The current study used in vivo signaling
analysis to discover an important role for
TLR2, IL-6, and STAT3 signaling in
Cell Host & Microbe
Previewsimmunity against poxviruses. This work
opens new areas of investigation in early
cytokine production and STAT signaling
in innate and acquired antiviral immune
responses and supports the development
of vaccine adjuvants that boost early
cytokine action in order to enhance
vaccine efficacy.
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